-+ 0.00%
-+ 0.00%
-+ 0.00%

HEMAB THERAPEUTICS ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 CLINICAL TRIAL OF HMB-003, AN INVESTIGATIONAL THERAPY FOR THE MANAGEMENT OF HEAVY MENSTRUAL BLEEDING

Reuters·09/17/2026 12:00:01

Please log in to view news